Critical Medicines Act EU seals deal on Critical Medicines Act after marathon talks After 12 hours of overnight negotiations, EU lawmakers reached a provisional agreement on the Critical Medicines Act aimed at boosting Europe’s pharmaceutical resilience
Inside EU Health Inside EU Health: Várhelyi; MEPs welcome medical devices reform; beating cancer plan Várhelyi investigation 'progress has been made'; ‘Let me be very clear, there will be no compromise on safety’ Várhelyi tells MEPs; Voiculescu calls for greater accountability in Europe’s cancer plan
Inside EU Health Inside EU Health: Europe invests in 10-year preparedness research plan; Biotech Act I rapporteurs; EU and Canada health agencies joint plan; HTA report Europe invests €240 million ten-year pandemic preparedness research; Biotech Act I rapporteurs confirmed; EU and Canada health agencies deepen ties; HTA annual report on first year of implementation
Cancer Europe’s Beating Cancer Plan: Progress made, but prevention falters Launched with much fanfare, the Parliament is examining what lessons can be learnt and how this can inform the cardiovascular plan expected soon
Critical Medicines Act Critical Medicines Act: Parliament ambition versus Council revision The Critical Medicines Act receives over a thousand proposed amendments from MEPs - while the Council is determined to weaken its provisions
